SCHEME 1
10-Hyd r oxy-10,9-bor oxa r op h en a n th r en es:
Ver sa tile Syn th etic In ter m ed ia tes to
3,4-Ben zocou m a r in s a n d Tr ia r yls
Q. J ean Zhou,* Karin Worm, and Roland E. Dolle
Department of Chemistry, Adolor Corporation, 700
Pennsylvania Drive, Exton, Pennsylvania 19341-1127
jzhou@adolor.com
Received April 19, 2004
Abst r a ct : 10-Hydroxy-10,9-boroxarophenanthrenes were
obtained as unexpected major products upon BBr3-mediated
O-demethylation of 2-methoxybiaryls. The formation likely
proceeds via intramolecular electrophilic aromatic cyclization
of a reactive dibromoaryloxyborane intermediate. Essentially
quantitative yields of 10-hydroxy-10,9-boroxarophenan-
threnes were also obtained from 2-hydroxybiaryl and BCl3/
AlCl3 with use of a modified literature procedure. As
synthetic intermediates, 10-hydroxy-10,9-boroxarophen-
anthrenes were efficiently converted to 3,4-benzocoumarins
and triaryls through Pd-catalyzed CO insertion and Suzuki
reaction.
SCHEME 2
While carrying out the O-demethylation of 1 with BBr3
under standard reaction conditions, we anticipated its
clean conversion to cannabinoid mimetic 2 (Scheme 1).1
To our surprise, an unknown compound 3 was isolated
in 65% yield while the desired product 2 was isolated in
only ∼10% yield. Although the demethylation reaction
was later accomplished in high yield with use of TMSI,
we were intrigued by what had transpired during the
BBr3 treatment and by the structure of the anomalous
product.
LC/MS analysis revealed that the unknown product
was a single compound containing one boron atom. The
material was stable to both strong aqueous acid and base
at 50 °C. It was smoothly transformed via oxidative
hydrolysis to a second unknown (94% yield), which was
readily identified as 2,2′-dihydroxybiphenyl 4 by 1H
NMR, 13C NMR, and LC/MS analysis (Scheme 1). This
latter transformation indicated that the boron atom was
attached directly to an aryl carbon atom. From these and
spectroscopic studies, the unknown compound was as-
required to facilitate boroxarene formation. The reaction
mechanism is believed to proceed through a common
dibromophenoxyborane intermediate (6) which, in the
absence of the 3′-methyl group (6a ,b), hydrolyzes to give
phenol. In the presence of the 3′-methyl group (6c), an
alternative pathway ensues: intramolecular electrophilic
aromatic substitution, re-aromatization upon loss of HBr,
then hydrolysis (8 f 9 f 10). The strict electronic
requirement within the biaryl substrate may explain why
boroxarene formation has never been reported as a side
reaction during BBr3-mediated O-demethylation.
The parent boroxarene 13 was previously prepared by
Dewar3 in 1960 upon treatment of 2-phenylphenol 7a
with BCl3 gas in hexane followed by the addition of AlCl3
(Scheme 3). Bridger4 subsequently found that the step-
wise addition of reagents was unnecessary. The yield in
both reports was ca. 65%. Boroxarenes have found limited
application in the literature, including their use as
antioxidant lubricant additives,5 Lewis acids for the aldol
condensation,6 and fungicides.7 However, there are no
reports employing boroxarenes as synthetic intermedi-
ates.
signed structure 3,
a substituted 10-hydroxy-10,9-
boroxarophenanthrene.2
To investigate the unexpected formation of 3 further,
we prepared 2-methoxybiphenyls 5a -c (Scheme 2), and
subjected them to the same reaction conditions as com-
pound 1. Interestingly, 5a ,b gave the anticipated phenols
7a ,b (100% yield), while 5c furnished 10 in quantitative
yield. It was clear that a 3′-methyl substituent was
(1) (a) Worm, K. I.; Zhou, Q. J .; Dolle, R. E. Solid-Phase Approach
To Biaryl Cannabinoid Mimetics; Abstracts of the 224th National
Meeting of the American Chemical Society, Boston, MA; American
Chemical Society: Washington, DC, 2002; ORGN 163. (b) Gareau, Y.;
Dufresne, C.; Gallant, M.; Rochette, C.; Sawyer, N.; Slipetz, D. M.;
Tremblay, N.; Weech, P. K.; Metters, K. M.; Labelle, M. Bioorg. Med.
Chem. Lett. 1996, 6, 189-194.
(3) Dewar, M. J . S.; Dietz, R. J . J . Chem. Soc. 1960, 1344.
(4) Bridger, R. F. U.S. Patent 4 210 599, 1980.
(5) Braid, M. U.S. Patent 4 353 807, 1982.
(6) Davis, F. A.; Dewar, M. J . S. J . Org. Chem. 1968, 8, 3324.
(7) Kohn, G. K.; McMurtry, R. J . U.S. Patent 3 686 398, 1972.
(2) This class of compound is collectively referred to herein as
boroxarenes.
10.1021/jo049343w CCC: $27.50 © 2004 American Chemical Society
Published on Web 06/25/2004
J . Org. Chem. 2004, 69, 5147-5149
5147